Literature DB >> 10732832

Antibody-mediated insulin resistance treated by cessation of insulin administration.

K Hara1, K Tobe, Y Uchigata, M Nakazono, K Yasuda, Y Terauchi, Y Iwamoto, Y Akanuma, S Kimura, T Kadowaki.   

Abstract

A 45-year-old Japanese man was referred to our hospital because of hyperglycemia despite the administration of as much as 120 U/day of human insulin. He had no history of injecting animal insulin. Free insulin was below 5 microU/ml, but a high titer of total insulin (about 3,000 microU/ml) was observed, suggesting the presence of antibodies against human insulin. Scatchard analysis showed an increased insulin binding capacity in the plasma characterized by a higher affinity for insulin. He was successfully treated by cessation of insulin administration. A Scatchard analysis series showed that a reduction in the insulin binding capacity of antibodies paralleled the improvement in glycemic control.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10732832     DOI: 10.2169/internalmedicine.39.143

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  5 in total

1.  Immunological insulin resistance due to insulin antibodies developed after cessation of insulin therapy in a patient with type 2 diabetes.

Authors:  Miho Hirano; Hiroshi Arima; Yutaka Oiso
Journal:  Diabetes Care       Date:  2008-11       Impact factor: 19.112

Review 2.  Exogenous insulin antibody syndrome (EIAS): a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients.

Authors:  Xiaolei Hu; Fengling Chen
Journal:  Endocr Connect       Date:  2017-12-12       Impact factor: 3.335

3.  Relationship between anti-insulin antibody production and severe insulin resistance in a diabetic cat.

Authors:  Takumi Komiya; Akihiro Mori; Naohito Nishii; Hitomi Oda; Eri Onozawa; Seri Seki; Toshinori Sako
Journal:  J Vet Med Sci       Date:  2021       Impact factor: 1.267

4.  Serious diabetic ketoacidosis induced by insulin allergy and anti-insulin antibody in an individual with type 2 diabetes mellitus.

Authors:  Kaio Takahashi; Takatoshi Anno; Haruka Takenouchi; Hideyuki Iwamoto; Megumi Horiya; Yukiko Kimura; Fumiko Kawasaki; Kohei Kaku; Koichi Tomoda; Hideaki Kaneto
Journal:  J Diabetes Investig       Date:  2022-05-31       Impact factor: 3.681

5.  The effects of liraglutide on both hypereosinophilic insulin allergy and the characteristics of anti-insulin antibodies in type 2 diabetes mellitus: a case report.

Authors:  Hiroyuki Hirai; Emi Ogata; Nobuyuki Kikuchi; Teruyuki Kohno; Noritaka Machii; Koji Hasegawa; Tsuyoshi Watanabe; Hiroaki Satoh
Journal:  J Med Case Rep       Date:  2016-07-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.